Get in touch

We are actively seeking strategic partnerships, clinical collaborators, and investors who share our mission to break down the biological barriers of cancer.

If you have questions about our CAR-Monocyte platform or are interested in exploring opportunities with KarMac, please reach out directly to our leadership team.

Dr. Jennifer Guerriero

Scientific discovery & platform development

jguerriero@bwh.harvard.edu

Dr. Thomas Marron

Clinical strategy & early phase trials

thomas.marron@mssm.edu

About Pipeline Founders News & Publications

Advisors Contact us

KarMac is a first-in-class CAR-Monocyte platform. We engineer immune cells to break down the biological shields around solid tumors, unlocking the immune system's full power to fight back.